Thanh bên bài viết
Số lượt xem PDF: 9
CLINICAL OUTCOMES OF TRANSURETHRAL THULIUM LASER ENUCLEATION OF THE PROSTATE IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA
Nội dung chính của bài viết
Tóm tắt
Objectives: To evaluate the safety and efficacy of Thulium laser enucleation of the prostate (ThuLEP) as a treatment for benign prostatic hyperplasia (BPH), with a focus on clinical, functional, and anatomical outcomes. Methods: A prospective, cross-sectional study was conducted on 92 patients diagnosed with BPH at Military Hospital 175 from September 2023 to December 2024. Data were collected on preoperative and postoperative clinical symptoms (IPSS score), urinary function (Qmax and PVR), anatomical outcomes, and quality of life (QoL). Comparative analyses were performed, and results were benchmarked against international literature. Results: A total of 92 patients diagnosed with BPH, with an average prostate volume of 72.48mL, were included in the study. The average surgery duration was 84.5 minutes, and hemoglobin dropped by 1.1 g/dL postoperatively. The mean IPSS improved significantly from 28.7 preoperatively to 1.3 at six months postoperatively. Qmax increased from 2.7 mL/s to 23.1 mL/s, and prostate volume decreased by more than 50% on average. At six months, 94.2% of patients achieved excellent treatment outcomes, with no severe complications observed. Additionally, patients reported substantial improvements in QoL, with mean QoL scores dropping from 5.8 preoperatively to 0.1. Conclusion: ThuLEP demonstrates safety and efficacy in managing BPH, offering significant symptom relief, functional improvements, and favorable anatomical outcomes.
Chi tiết bài viết
Từ khóa
Lower urinary tract symptom, Benign prostatic hyperplasia, Thulium laser enucleation of the prostate
Tài liệu tham khảo
2. Chen CH, Chung CH, Chu HC, et al. Surgical outcome of anatomical endoscopic enucleation of the prostate: A systemic review and meta-analysis. Andrologia. 2020; 52(8):e13612.
3. Herrmann TR, Bach T, Imkamp F, et al. Thulium laser enucleation of the prostate (ThuLEP): Transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol. 2010; 28(1):45-51.
4. Bozzini G, Berti L, Maltagliati M, et al. Current evidence of ThuLEP for BPH: A review of literature. Turk J Urol. 2021; 47(6):461-469.
5. You C, Li X, Du Y, et al. Comparison of different laser-based enucleation techniques for benign prostate hyperplasia: A systematic review and meta-analysis. Int J Surg. 2021; 94:106135.
6. Zhang Y, Yuan P, Ma D, et al. Efficacy and safety of enucleation vs. resection of prostate for treatment of benign prostatic hyperplasia: A meta-analysis of randomized controlled trials. Prostate Cancer Prostatic Dis. 2019; 22(4):493-508.
7. Homma Y, Kawabe K, Tsukamoto T, et al. Estimate criteria for efficacy of treatment in benign prostatic hyperplasia. Int J Urol. 1996; 3:267-273.
8. Pang KH, Ortner G, Yuan Y, et al. Complications and functional outcomes of endoscopic enucleation of the prostate: A systematic review and meta-analysis of randomised-controlled studies. Cent European J Urol. 2022; 75(4):357-386.
9. Kim YJ, Lee YH, Kwon JB, et al. A novel one lobe technique of thulium laser enucleation of the prostate: “All-in-One” technique. Korean J Urol. 2015; 56(11):769-774.
10. Huang SW, Tsai CY, Tseng CS, et al. Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: Systematic review and network meta-analysis. BMJ. 2019; 367:l5919.